HEREAT Human Molecular
Genetics and Epigenetics
Research Laboratory

Prof. Eda Tahir Turanlı is a distinguished scientist and academician in the field of molecular biology and genetics. Her educational journey began in the United Kingdom, where she obtained a Bachelor of Science (BSc) degree in Genetics from the University of Nottingham, followed by a Master of Science (MSc) in Human Molecular Genetics from the Imperial College of Science and Technology in London. She then returned to Turkey to complete her PhD in Medical Biology and Genetics at Marmara University, focusing on the genetic intricacies underlying complex diseases. In addition to her academic achievements, Prof. Turanlı gained valuable research experience between 1999 and 2001 at the MRC Centre for Social, Genetic, and Developmental Psychiatry Research, Institute of Psychiatry, King's College, University of London, and from 1997 to 2001 at the Marmara Research Center under The Scientific and Technological Research Council of Turkey (TÜBİTAK).
Prof. Turanlı's research focuses on genomics and molecular genetics, with a strong emphasis on understanding the genetic basis of complex diseases such as multiple sclerosis, familial Mediterranean fever, and various autoinflammatory disorders. Utilizing advanced techniques such as exome sequencing, linkage analysis, and proteomics, she has made significant strides in identifying genetic variants and molecular pathways associated with these conditions. Her work not only contributes to the scientific community's understanding of these diseases but also has practical implications for developing diagnostic tools and therapeutic strategies. Prof. Turanlı's dedication to research and education has established her as a leading figure in her field, with a lasting impact on both the scientific and medical communities.

All papers under Eda’s ORCID:

2022

Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation
Everest E., Ahangari M., Uygunoglu U., Tutuncu M., Bulbul A., Saip S., et al. Turanli E.T.
SCIENTIFIC REPORTS · 2022 · doi:10.1038/s41598-022-21484-x

2024

Var3PPred: variant prediction based on 3-D structure and sequence analyses of protein-protein interactions on autoinflammatory diseases.
Bülbül, A., Timucin, E., Timuçin, A. C., Sezerman, O. U., & Turanli, E. T.
PeerJ · 2024 · doi:10.7717/peerj.17297

2024

A rare case of uncharacterized autoinflammatory disease: Patient carrying variations in NLRP3 and TNFRSF1A genes
Kilinc, O. C., Gayibova, K., Onen, M. O., Onat, U. I., Bülbül, A., Timucin, A. C., Ugurlu, S., & Turanli, E. T.
American journal of medical genetics · 2024 · doi:10.1002/ajmg.a.63715

2024

HLA-B gene methylation and expression in Behçet's syndrome: a potential role of epigenetics in the pathogenesis
Özkılınç Önen, M., Everest, E., Demirci, T., Köprülü Şen, P., Kızıltepe Kısakesen, E., Özgüler, Y., Esatoğlu, S. N., Seyahi, E., & Tahir Turanlı, E.
Clinical and experimental rheumatology · 2024 · doi:10.55563/clinexprheumatol/1sf43v

2023

Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotype
Özkılınç Önen, M., Onat, U. I., Uğurlu, S., Timuçin, A. C., Öz Arslan, D., Everest, E., Özdoğan, H., & Tahir Turanlı, E.
Rheumatology (Oxford, England) · 2023 · doi:10.1093/rheumatology/kead044

2023

Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers.
Everest E., Uygunoglu U., Tutuncu M., Bulbul A., Onat U. İ., Unal M., et al. Turanli E.T.
PloS one · 2023 · doi:10.1371/journal.pone.0287463